Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Plos One|April 15, 2026
Nutritional prehabilitation in head and neck cancer patients (PreHead) - A randomized controlled trial study protocolD Sijbrands, D Gort-van Dijk, S A H J de Visscher, et al.
International Journal of Cancer|July 29, 2011
A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patientsJ J H Eijsink, Á Lendvai, V Deregowski, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2024
Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the NetherlandsV D de Jager, B N Cajiao Garcia, C C H J Kuijpers, et al.
Clinical Epigenetics|March 11, 2016
Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3A Boers, R Wang, R W van Leeuwen, et al.
Breast (Edinburgh, Scotland)|September 18, 2016
Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendeesC M G van Driel, J C Oosterwijk, E J Meijers-Heijboer, et al.
British Journal of Cancer|August 2, 2006
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studiesP de Graeff, J Hall, A P G Crijns, et al.
European Journal of Human Genetics : EJHG|August 2, 2003
Possible consequences of applying guidelines to healthy women with a family history of breast cancerC J van Asperen, R A E M Tollenaar, E M M Krol-Warmerdam, et al.
Journal of Medical Genetics|October 7, 2004
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantG H de Bock, M Schutte, E M M Krol-Warmerdam, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 4, 2015
Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort studyM G Huisman, R A Audisio, G Ugolini, et al.
British Journal of Cancer|April 17, 2015
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patientsR G Koleva-Kolarova, M J W Greuter, M van Kruchten, et al.
Pageof 19